Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic G Barr

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Nature Genetics|May 6, 2014
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutationsShinji Kohsaka, Neerav Shukla, Nabahet Ameur, et al.
Cancer Research|January 10, 2002
Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patientsMarc Ladanyi, Cristina R Antonescu, Denis H Leung, et al.
Cancer Research|April 3, 2009
Credentialing a preclinical mouse model of alveolar rhabdomyosarcomaKoichi Nishijo, Qing-Rong Chen, Lei Zhang, et al.
Frontiers in Oncology|January 3, 2022
Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical EfficacyHoyoung M Maeng, Brittni N Moore, Hadi Bagheri, et al.
Cancer Cell|February 15, 2011
Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcomaBrian P Rubin, Koichi Nishijo, Hung-I Harry Chen, et al.
Cancer Discovery|April 28, 2017
PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain VulnerabilityBerkley E Gryder, Marielle E Yohe, Hsien-Chao Chou, et al.
Cold Spring Harbor Perspectives in Medicine|November 5, 2014
Rhabdomyosarcoma: current challenges and their implications for developing therapiesSimone Hettmer, Zhizhong Li, Andrew N Billin, et al.
Cancer Discovery|January 18, 2014
Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumorsJack F Shern, Li Chen, Juliann Chmielecki, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitionAngela Kim, Prateek Bhardwaj, Collin D Heer, et al.
Molecular Cancer Therapeutics|April 22, 2026
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitionAngela Kim, Prateek Bhardwaj, Shahyan Rehman, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Nature Genetics|May 6, 2014
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutationsShinji Kohsaka, Neerav Shukla, Nabahet Ameur, et al.
Cancer Research|January 10, 2002
Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patientsMarc Ladanyi, Cristina R Antonescu, Denis H Leung, et al.
Cancer Research|April 3, 2009
Credentialing a preclinical mouse model of alveolar rhabdomyosarcomaKoichi Nishijo, Qing-Rong Chen, Lei Zhang, et al.
Frontiers in Oncology|January 3, 2022
Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical EfficacyHoyoung M Maeng, Brittni N Moore, Hadi Bagheri, et al.
Cancer Cell|February 15, 2011
Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcomaBrian P Rubin, Koichi Nishijo, Hung-I Harry Chen, et al.
Cancer Discovery|April 28, 2017
PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain VulnerabilityBerkley E Gryder, Marielle E Yohe, Hsien-Chao Chou, et al.
Cold Spring Harbor Perspectives in Medicine|November 5, 2014
Rhabdomyosarcoma: current challenges and their implications for developing therapiesSimone Hettmer, Zhizhong Li, Andrew N Billin, et al.
Cancer Discovery|January 18, 2014
Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumorsJack F Shern, Li Chen, Juliann Chmielecki, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitionAngela Kim, Prateek Bhardwaj, Collin D Heer, et al.
Molecular Cancer Therapeutics|April 22, 2026
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitionAngela Kim, Prateek Bhardwaj, Shahyan Rehman, et al.
Pageof 10